8 Vaccines Approved for Use in Japan
-
Takeda
TAK-019 (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
3 trials in 1 country
Approval Source: reuters.com
-
Moderna
Spikevax Bivalent Original/Omicron BA.1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 38 countries
5 trials in 4 countries
Approval Source: stockhouse.com
-
Moderna
Spikevax Bivalent Original/Omicron BA.4/BA.5- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
2 trials in 1 country
Approval Source: english.kyodonews.net
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
Approval Source: japantimes.co.jp
-
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 35 countries
3 trials in 5 countries
Approval Source: bloomberg.com
-
Pfizer/BioNTech
Comirnaty Bivalent Original/Omicron BA.4/BA.5- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 33 countries
4 trials in 1 country
Approval Source: english.kyodonews.net
-
Takeda
TAK-919 (Moderna formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
Approval Source: takeda.com
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
73 trials in 34 countries
Approval Source: astrazeneca.com
14 Vaccines in Clinical Trials in Japan
-
Shionogi
S-268019- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
9 trials in 2 countries
-
Takeda
TAK-019 (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
3 trials in 1 country
-
Medicago
Covifenz- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
6 trials in 6 countries
-
AnGes
AG0302-COVID19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
8 trials in 1 country
-
Daiichi Sankyo Co Ltd
DS-5670a- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 1 country
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
70 trials in 24 countries
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
-
Janssen (Johnson & Johnson)
Jcovden- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 113 countries
26 trials in 25 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
73 trials in 34 countries
-
KM Biologics Co Ltd
KD-414- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
7 trials in 2 countries
-
AnGes
AG0301-COVID19- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Elixirgen Therapeutics Inc
EXG-5003- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country
-
Takeda
TAK-919 (Moderna formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 1 country
2 trials in 1 country
-
VLP Therapeutics Japan
VLPCOV-01- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country